NEWS

What do your key players need from IT systems in your CGT processes?

4 May 2022
Advanced Therapy Medicinal Products
Information Technology
BioPhorum

Manufacturing cell and gene therapies (CGTs) usually involve the coordinated efforts of staff in treatment centres, shipping partners, and more than one manufacturing facility. It has become complex because each new therapy seems to define a contrasting way of doing things and has a different way of interacting across various combinations of the same companies. So how can we align processes? And how can we get to a level of digital maturity?

Overcoming this challenge needs new levels of collaboration and coordination between people and systems in different organizations. This should identify what each person needs from their IT systems and bring together data and processes in a coordinated way.

This is a complex challenge and is where BioPhorum is playing a key role. Its latest deliverable is a new toolkit that will support industry needs while reducing the costs for CGT manufacturers and software vendors, and the overall times for CGT treatments. It will also improve flexibility, regulatory compliance and integration between systems.

Unique toolkit

CGT personas and user stories: What people need the systems to do to support the supply of cell and gene therapies is a part of a unique toolkit that details the needs of all the key players involved in end-to-end CGT processes. It comes with an associated spreadsheet and editable presentation slides so that the combined knowledge of the authors can be directly used and adapted to accelerate analysis and design activities for systems to support CGTs.

The toolkit details what each of the key players (personas) in the end-to-end CGT supply process needs from the systems (user stories). It reveals commonality across therapy types and pinpoints where users in different organizations have similar IT needs. Most importantly, it explains what those users are trying to do and the reasons why, so that solutions can be built with a proper understanding of the true underlying needs.

The toolkit provides a common language and framework for collaboration that can be used by manufacturers of CGT products, contract manufacturing organizations, treatment centres, shipping partners, vendors and developers of IT systems, and regulators.

The companion document CGT actors and process maps explains who does what in the supply of different CGTs.

The toolkit will accelerate the analysis and design of IT solutions to support CGT supply – and is full of nuances and tips based on real-life experiences that will smooth the path for everyone taking this journey. These will fast-track the delivery of well-formed solutions that are useful, usable and used.

It will help designers consider scenarios where their organization may be handling other therapy types in the future. If IT solutions built today can support multiple therapy types, future therapies can be brought to market more quickly and be supported more easily.

Whether you are just considering entering the CGT field or are a more established player, the toolkit will help you think carefully about the needs of everybody involved in the end-to-end CGT process using a common language. The future will have many more supply partnerships and to remain agile as an industry, we need to work in common ways.

By identifying and describing the actors and personas, and listing the distinctive user stories for each, this toolkit is a small but significant step in understanding the complexity of CGT delivery.

Data Integrity Words On Dark Background
NEWS
Tackling the five crucial data integrity challenges in QC labs
Digital arrow, blue
NEWS
Where to start with your biomanufacturing digital transformation
NEWS
BioPhorum’s vision for standardizing the traceability of CGTs
NEWS
Are you ready for a cyberattack on your OT systems?
Digital face, data
NEWS
On your marks, get set, go! How to start your data governance project

Advanced Therapy Medicinal Products

Advanced Therapy Medicinal Products support the quest for better and faster development of cell, gene and RNA therapies​ through connecting therapy developers, contract manufacturing, and testing organizations to gain an understanding and respond to the challenges faced by the advanced therapeutics industry.

Development Group

Development Group accelerates and improves the development process of biopharmaceutical medicines for the benefit of the patient. Replacing isolation with collaboration by providing a “safe” space where subject matter experts can work on sharing solutions and best practice on emerging industry trends, implementation of new technologies and common issues whilst ensuring their intellectual property and confidentiality is protected.

Drug Substance

Drug Substance advances excellence in drug substance manufacturing and testing, acting as an industry voice to accelerate technology adoption, implement post-approval change more rapidly and increase confidence in maintaining compliance.

Fill Finish

Fill Finish accelerates development and acceptance of sustainable world-class filling and packaging operations for drug product which meets the future needs of patients. Through innovative solutions resulting from the sharing of expertise, we can overcome common performance challenges and deliver on quality and regulatory compliance.

Information Technology

Information Technology accelerates digital maturity across the ​global pharmaceutical manufacturing industry.

Quality

BioPhorum Quality provides a dedicated, safe space for quality professionals from biomanufacturers and contract organizations to coalesce and enhance effective collaboration to address shared industry challenges.

Regulatory-CMC

Regulatory CMC brings leaders together who have a common goal – to improve access to medicines through innovation in the Regulatory ecosystem. It provides a dedicated space for strategic leadership and a coordinated industry voice, to move from divergence to convergence.

Supply Chain to Patient

Supply Chain to Patient transforms the performance of global pharmaceutical clinical and commercial outbound supply chains through industry collaboration by creating transparent patient-centric, resilient and agile E2E supply chains, that consistently deliver high-quality medicines ensuring an uninterrupted supply to patients.

Supply Partner

Supply Partner is a trusted advisory group and collaboration that is the engine for driving change across the global industry for all things relevant to the inbound supply chain. Addressing the challenges of complexity, resilience, cost, sustainability, and innovation.

Sustainability

Sustainability enables the industry’s transition to a low carbon, circular future – supporting members to improve patient health while respecting the planet. We activate multi-disciplinary teams drawn from our network to deliver environmental sustainability improvements across the value chain.

Technology Strategy

Technology Strategy acts as one voice of the industry to define strategy, accelerate technology transformation and support technology translation and adoption. With a purpose of enabling the future state of flexible, resilient, sustainable end-to-end biomanufacturing.

DOWNLOAD
An industry perspective on understanding AAV capsid content variants
Needle On Yellow Background
EXTERNAL-RESOURCE
An intercompany perspective on practical experiences of predicting, optimizing and analyzing high concentration biologic therapeutic formulations
DOWNLOAD
The Drug Substance 2.0 Strategic Value Framework
Coloured dots on teal, next to vial
DOWNLOAD
BioPhorum’s holistic approach to container closure integrity
Magnifying glass over a tablet all coloured blue
DOWNLOAD
Digital Plant Maturity Model 3.0
NEWS
Inaugural BioPhorum Quality face to face – get involved
PODCAST
The next step in building regulatory as a capability to enable strategic innovation across the BioPhorum community
PODCAST
Delivering a Cell and Gene Therapy Outbound Supply Chain Pathway for the Industry
DNA and Earth on blue background
DOWNLOAD
A vision for the biopharmaceutical industry’s inbound supply chain
NEWS
A major milestone – a harmonized approach to product carbon footprint data
Technology Roadmap V 2.0
DOWNLOAD
BioPhorum Technology Roadmapping roadmap vision 2.0

Publications

Documents including best practices, vision statements and peer reviewed papers to help you take value back to your business.

Webinars

Discussing all aspects of the biopharmaceutical industry, from digitization and knowledge management to raw materials, supply chain, sustainability and more. Learn from the perspectives of those at the forefront of the industry.

Podcasts

BioPhorum Connect is our podcast series that keeps you up to date with the latest news and trends in the biopharmaceutical industry. From experienced professionals to thought leaders, these podcasts bring you the insights and perspectives of experts from around the world.

Tools

A variety of resources including design tools and user requirement specifications to help you improve and streamline your business processes.

Benchmarks and Surveys

Research conducted among the BioPhorum membership providing evidence to support change and identify best practice.

Browse all

Access a variety of free tools and papers and other resources designed to provide you with up-to-date information and insights to help you make informed decisions and maximize your success. Access our resources today and start making improving and streamlining your business processes.

WEBINAR
Bioreactivity testing in single-use system biomanufacturing
WEBINAR
Bioreactivity testing in single-use system biomanufacturing
WEBINAR
Bioreactivity testing in single-use system biomanufacturing
Magnifying glass over a tablet all coloured blue
DOWNLOAD
Digital Plant Maturity Model 3.0
WEBINAR
Bioreactivity testing in single-use system biomanufacturing